A. Garin

4.1k total citations · 1 hit paper
26 papers, 1.9k citations indexed

About

A. Garin is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Garin has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Garin's work include Testicular diseases and treatments (9 papers), Neuroblastoma Research and Treatments (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). A. Garin is often cited by papers focused on Testicular diseases and treatments (9 papers), Neuroblastoma Research and Treatments (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). A. Garin collaborates with scholars based in Russia, United Kingdom and United States. A. Garin's co-authors include Richard Sylvester, Hendrik Van Poppel, Linda de Prijck, J. McKendrick, Jean A. Maroun, Ullrich Graeven, B Osterwalder, John L. Marshall, Paulo M. Hoff and Ulrich Bürger and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

A. Garin

25 papers receiving 1.8k citations

Hit Papers

Radical nephrectomy plus interferon-alfa-based immunother... 2001 2026 2009 2017 2001 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
    2001 1.0k citations A. Garin, Hendrik Van Poppel et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Garin Russia 10 1.2k 777 644 538 422 26 1.9k
Paul E. Van Schil Belgium 19 2.0k 1.6× 1.2k 1.6× 327 0.5× 436 0.8× 378 0.9× 68 2.7k
Piotr Czaykowski Canada 23 1.2k 1.0× 857 1.1× 796 1.2× 440 0.8× 604 1.4× 89 2.2k
Pınar Saip Türkiye 21 520 0.4× 606 0.8× 288 0.4× 337 0.6× 354 0.8× 115 1.6k
Francis Daniel United Kingdom 5 1.5k 1.2× 960 1.2× 225 0.3× 775 1.4× 70 0.2× 5 2.0k
Enrique Gallardo Spain 18 621 0.5× 480 0.6× 500 0.8× 571 1.1× 315 0.7× 90 1.6k
Cristina Granetto Italy 16 944 0.8× 2.4k 3.1× 285 0.4× 553 1.0× 320 0.8× 64 2.9k
Aurélie Le Maître Canada 16 1.7k 1.4× 1.2k 1.6× 390 0.6× 1.7k 3.1× 282 0.7× 38 3.8k
Albrecht Kretzschmar Germany 21 1.5k 1.2× 1.6k 2.0× 152 0.2× 721 1.3× 83 0.2× 71 2.5k
Heung Moon Chang South Korea 27 1.2k 1.0× 1.3k 1.7× 226 0.4× 816 1.5× 138 0.3× 80 2.2k
Michele De Tursi Italy 18 310 0.3× 576 0.7× 239 0.4× 144 0.3× 304 0.7× 60 1.3k

Countries citing papers authored by A. Garin

Since Specialization
Citations

This map shows the geographic impact of A. Garin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Garin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Garin more than expected).

Fields of papers citing papers by A. Garin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Garin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Garin. The network helps show where A. Garin may publish in the future.

Co-authorship network of co-authors of A. Garin

This figure shows the co-authorship network connecting the top 25 collaborators of A. Garin. A scholar is included among the top collaborators of A. Garin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Garin. A. Garin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garin, A., et al.. (2020). Delirium tremens : quoi de neuf pour une vieille maladie ?. La Revue de Médecine Interne. 42(5). 330–337. 1 indexed citations
2.
3.
4.
Покатаев, И. А., et al.. (2010). A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy. Annals of Oncology. 21(9). 1779–1785. 50 indexed citations
5.
Tryakin, A., et al.. (2010). Paclitaxel plus BEP (T-BEP) regimen as induction chemotherapy (CT) in nonseminomatous germ cell tumors (NSGCT) patients with poor prognosis: A phase II study.. Journal of Clinical Oncology. 28(15_suppl). 4587–4587. 2 indexed citations
6.
Garin, A., et al.. (2009). [Targeted drugs for the treatment of disseminated colonic cancer].. PubMed. 17–20. 1 indexed citations
7.
Karthaus, Meinolf, Albrecht Kretzschmar, H. Kröning, et al.. (2005). Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Annals of Oncology. 17(2). 289–296. 159 indexed citations
8.
Gilliam, A, A. Garin, S A Watson, et al.. (2004). Randomised, double blind, placebo-controlled, multi-centre, group-sequential trial of G17DT for patients with advanced pancreatic cancer unsuitable or unwilling to take chemotherapy. Journal of Clinical Oncology. 22(14_suppl). 2511–2511. 18 indexed citations
9.
Gilliam, A, A. Garin, SA Watson, et al.. (2004). Randomised, double blind, placebo-controlled, multi-centre, group-sequential trial of G17DT for patients with advanced pancreatic cancer unsuitable or unwilling to take chemotherapy. Journal of Clinical Oncology. 22(14_suppl). 2511–2511. 4 indexed citations
10.
Cassidy, Jim, Chris Twelves, Eric Van Cutsem, et al.. (2002). First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin. Annals of Oncology. 13(4). 566–575. 422 indexed citations
11.
Vukelja, S., Vladimir Moiseyenko, Robert Leonard, et al.. (2001). Xeloda (capecitabine) plus docetaxel combination therapy in locally advanced/metastatic breast cancer: Latest results. Breast Cancer Research and Treatment. 69(3). 6 indexed citations
12.
Garin, A., et al.. (2001). Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. The Lancet. 358(9286). 966–970. 1006 indexed citations breakdown →
13.
Garin, A., et al.. (2001). [Results of a phase I clinical trial of "theraphthal + ascorbic acid" catalytic system].. PubMed. 47(6). 676–9. 3 indexed citations
14.
Bazin, I., et al.. (1999). Gemzar (GEM) + Mitimycin C (MMC) in patients with advanced pancreatic cancer (APC). European Journal of Cancer. 35. S151–S151. 3 indexed citations
15.
16.
Tjulandin, S., A. Garin, Н И Переводчикова, et al.. (1993). Cisplatin-etoposide and carboplatin-etoposide induction chemotherapy for good-risk patients with germ cell tumor. Annals of Oncology. 4(8). 663–667. 16 indexed citations
17.
Tjulandin, S., et al.. (1993). Long term results of treatment in patients with extragonadal germ cell tumours. European Journal of Cancer. 29(7). 1002–1005. 23 indexed citations
18.
Tjulandin, S., et al.. (1991). VAB-6 and cisplatin-cyclophosphamide combinations in the treatment of metastatic seminoma patients: The U.S.S.R. experience. Annals of Oncology. 2(9). 667–672. 4 indexed citations
19.
Borie, Consuelo, et al.. (1990). [A family outbreak of acute hepatic fascioliasis].. PubMed. 118(1). 67–72. 3 indexed citations
20.
Garin, A., et al.. (1985). [Combination of platidiam and bleomycetin in disseminated skin melanoma].. PubMed. 30(10). 780–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul E. Van Schil Breakdown of academic impact, for papers by Piotr Czaykowski Breakdown of academic impact, for papers by Pınar Saip Breakdown of academic impact, for papers by Francis Daniel Breakdown of academic impact, for papers by Enrique Gallardo Breakdown of academic impact, for papers by Cristina Granetto Breakdown of academic impact, for papers by Aurélie Le Maître Breakdown of academic impact, for papers by Albrecht Kretzschmar Breakdown of academic impact, for papers by Heung Moon Chang Breakdown of academic impact, for papers by Michele De Tursi
Rankless by CCL
2026